Qube Research & Technologies (QRT)
THRD

Qube Research & Technologies (QRT)’s Third Harmonic Bio THRD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97,024
Closed -$527K – 3953
2025
Q2 		$527K Sell
97,024
-62,350
-39% -$311K ﹤0.01% 2674
2025
Q1 		$553K Buy
+159,374
New +$773K ﹤0.01% 2505
2024
Q4 		– Sell
-20,125
Closed -$273K – 3821
2024
Q3 		$273K Buy
20,125
+15,841
+370% +$196K ﹤0.01% 2463
2024
Q2 		$55.7K Sell
4,284
-12,491
-74% -$155K ﹤0.01% 2724
2024
Q1 		$158K Buy
+16,775
New +$163K ﹤0.01% 3132
2022
Q4 		– Sell
-27,800
Closed -$527K – 2995
2022
Q3 		$527K Buy
+27,800
New +$501K ﹤0.01% 1446

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s THRD Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 97,024 shares — an estimated $527K sold.

Qube Research & Technologies (QRT) first reported a position in THRD in Q3 2022 and held it in 6 quarters. The position peaked at $553K in Q1 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 97,024 Third Harmonic Bio shares in Q3 2025, an estimated $527K.
  • Qube Research & Technologies (QRT) first reported a position in Third Harmonic Bio in Q3 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Third Harmonic Bio position peaked at $553K in Q1 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.